Evidence-based clinical practice guidelines for IgA nephropathy 2014

被引:61
作者
Yuzawa, Yukio [1 ]
Yamamoto, Ryohei [2 ]
Takahashi, Kazuo [1 ]
Katafuchi, Ritsuko [3 ]
Tomita, Makoto [1 ]
Fujigaki, Yoshihide [4 ]
Kitamura, Hiroshi [5 ]
Goto, Masashi [6 ]
Yasuda, Takashi [7 ]
Sato, Mitsuhiro [8 ]
Urushihara, Maki [9 ]
Kondo, Shuji [9 ]
Kagami, Shoji [9 ]
Yasuda, Yoshinari [10 ]
Komatsu, Hiroyuki [11 ]
Takahara, Miki [12 ]
Harabuchi, Yasuaki [12 ]
Kimura, Kenjiro [13 ]
Matsuo, Seiichi [10 ]
机构
[1] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan
[2] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[3] Natl Fukuoka Higashi Med Ctr, Koga, Japan
[4] Teikyo Univ, Sch Med, Tokyo, Japan
[5] Chiba East Hosp, Chiba, Japan
[6] Kyoto Med Ctr, Kyoto, Japan
[7] Kichijoji Asahi Hosp, Tokyo, Japan
[8] JCHO Sendai Hosp, Sendai, Miyagi, Japan
[9] Univ Tokushima, Grad Sch, Tokushima, Japan
[10] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[11] Univ Miyazaki Hosp, Miyazaki, Japan
[12] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan
[13] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan
关键词
IMMUNOGLOBULIN-A NEPHROPATHY; HUMAN MESANGIAL CELLS; HENOCH-SCHONLEIN PURPURA; CIRCULATING IMMUNE-COMPLEXES; STEROID PULSE THERAPY; GALACTOSE-DEFICIENT IGA1; HUMAN SERUM IGA1; SINGLE-NUCLEOTIDE POLYMORPHISMS; TONSILLAR MONONUCLEAR-CELLS; RANDOMIZED CONTROLLED-TRIAL;
D O I
10.1007/s10157-015-1223-y
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:511 / 535
页数:25
相关论文
共 520 条
[1]  
AARONS I, 1989, CLIN NEPHROL, V32, P151
[2]   Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney [J].
Abe, K ;
Miyazaki, M ;
Koji, T ;
Furusu, A ;
Ozono, Y ;
Harada, T ;
Sakai, H ;
Nakane, PK ;
Kohno, S .
KIDNEY INTERNATIONAL, 1998, 54 (01) :120-130
[3]   Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy [J].
Abe, K ;
Miyazaki, M ;
Koji, T ;
Furusu, A ;
Shioshita, K ;
Tsukasaki, S ;
Ozono, Y ;
Harada, T ;
Sakai, H ;
Kohno, S .
NEPHRON, 2001, 87 (03) :231-239
[4]   CRESCENTIC IGA NEPHROPATHY [J].
ABUELO, JG ;
ESPARZA, AR ;
MATARESE, RA ;
ENDRENY, RG ;
CARVALHO, JS ;
ALLEGRA, SR .
MEDICINE, 1984, 63 (06) :396-406
[5]   Long-term results of tonsillectomy as a treatment for IgA nephropathy [J].
Akagi, H ;
Kosaka, M ;
Hattori, K ;
Doi, A ;
Fukushima, K ;
Okano, M ;
Kariya, S ;
Nishizaki, K ;
Sugiyama, N ;
Shikata, K ;
Makino, H ;
Masuda, Y .
ACTA OTO-LARYNGOLOGICA, 2004, 124 :38-42
[6]   Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy [J].
Akiyama, F ;
Tanaka, T ;
Yamada, R ;
Ohnishi, Y ;
Tsunoda, T ;
Maeda, S ;
Takei, T ;
Obara, W ;
Ito, K ;
Honda, K ;
Uchida, K ;
Tsuchiya, K ;
Nitta, K ;
Yumura, W ;
Nihei, H ;
Ujiie, T ;
Nagane, Y ;
Miyano, S ;
Suzuki, Y ;
Fujioka, T ;
Narita, I ;
Gejyo, F ;
Nakamura, Y .
JOURNAL OF HUMAN GENETICS, 2002, 47 (10) :532-538
[7]  
ALAMARTINE E, 1990, CLIN NEPHROL, V34, P45
[8]   The Use of the Oxford Classification of IgA Nephropathy to Predict Renal Survival [J].
Alamartine, Eric ;
Sauron, Catherine ;
Laurent, Blandine ;
Sury, Aurore ;
Seffert, Aline ;
Mariat, Christophe .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10) :2384-2388
[9]   Treatment of severe IgA nephropathy with omega-3 fatty acids: The effect of a "very low dose" regimen [J].
Alexopoulos, E ;
Stangou, M ;
Pantzaki, A ;
Kirmizis, D ;
Memmos, D .
RENAL FAILURE, 2004, 26 (04) :453-459